Cargando…
Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies
In the past decade, treatments targeting the immune system have revolutionized the cancer treatment field. Therapies such as immune checkpoint inhibitors have been approved as first-line treatment in a variety of solid tumors such as melanoma and non-small cell lung cancer while other therapies, for...
Autores principales: | Magré, Luc, Verstegen, Monique M A, Buschow, Sonja, van der Laan, Luc J W, Peppelenbosch, Maikel, Desai, Jyaysi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10231025/ https://www.ncbi.nlm.nih.gov/pubmed/37220953 http://dx.doi.org/10.1136/jitc-2022-006290 |
Ejemplares similares
-
Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification
por: Lieshout, Ruby, et al.
Publicado: (2022) -
Oncoimmunology Meets Organs-on-Chip
por: Mattei, Fabrizio, et al.
Publicado: (2021) -
Opportunities for Conventional and In Situ Cancer Vaccine Strategies and Combination with Immunotherapy for Gastrointestinal Cancers, A Review
por: Bouzid, Rachid, et al.
Publicado: (2020) -
Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells
por: Zhou, Guoying, et al.
Publicado: (2022) -
Rotavirus Infection and Cytopathogenesis in Human Biliary Organoids Potentially Recapitulate Biliary Atresia Development
por: Chen, Sunrui, et al.
Publicado: (2020)